Isoniazid Tablet
Product Images NDC 64950-217

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Isoniazid (NDC 64950-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genus Lifesciences, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Isoniazid 01)

Chemical structure of isoniazid depicted as a molecular formula diagram showing a pyridine ring linked to a hydrazide group.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Isoniazid Tablets USP 100 mg oral tablets, packaged in a container labeled for prescription use with a quantity of 100 tablets. The label indicates the product is manufactured for Genus Lifesciences Inc., Allentown, PA, and manufactured in Canada by Patheon Inc. Storage instructions specify controlled room temperature and protection from moisture and light.*

FDA Label Image

Principal Display Panel (300 mg Tablet Bottle Label)

Label for Isoniazid Tablets, USP 300 mg oral tablets by Genus Lifesciences. The label indicates a package of 100 tablets. It includes storage instructions to keep at 20° to 25°C (68° to 77°F) and protect from moisture and light. The drug is manufactured in Canada by Patheon Inc. and for Genus Lifesciences in Allentown, PA. The NDC is 64950-217-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.